ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,275,000 | +93.9% | 70,700 | +2.0% | 0.02% | +87.5% |
| Q1 2019 | $1,689,000 | +122.2% | 69,300 | +29.8% | 0.01% | +100.0% |
| Q4 2018 | $760,000 | -13.9% | 53,400 | -8.1% | 0.00% | 0.0% |
| Q3 2018 | $883,000 | -18.1% | 58,100 | -9.6% | 0.00% | -20.0% |
| Q2 2018 | $1,078,000 | +213.4% | 64,300 | +204.7% | 0.01% | +150.0% |
| Q1 2018 | $344,000 | +1223.1% | 21,100 | +904.8% | 0.00% | – |
| Q4 2017 | $26,000 | +2500.0% | 2,100 | +2000.0% | 0.00% | – |
| Q3 2017 | $1,000 | -98.5% | 100 | -98.7% | 0.00% | – |
| Q2 2017 | $65,000 | -90.9% | 7,800 | -95.0% | 0.00% | -100.0% |
| Q3 2015 | $716,000 | – | 157,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |